The Hidden Cardiac Amyloidosis and Red Flags: Case Report

Manuel De La Cruz Seoane¹, Sahar S Abdelmoneim^1, , Sandy Espinosa Hernandez¹, Madeleidis Lopez Leon¹, Lauren Alcantara Navarro¹, Rishbha Dua¹, Odalys Frontela¹ and Sabas I Gomez¹

¹Division of Internal Medicine, Larkin Palm Spring Community Hospital, 1475 W 49th Pl, Hialeah, FL 33012

Cite this paper

Manuel De La Cruz Seoane, Sahar S Abdelmoneim, Sandy Espinosa Hernandez, Madeleidis Lopez Leon, Lauren Alcantara Navarro, Rishbha Dua, Odalys Frontela and Sabas I Gomez. The Hidden Cardiac Amyloidosis and Red Flags: Case Report. American Journal of Clinical Medicine Research. 2022; 10(2):32-35. doi: 10.12691/AJCMR-10-2-1

Abstract

It is imperative that internists and hospitalists who are the frontier of care seen by the patient are aware of the red flags associated with cardiac amyloidosis. This case report discusses the clinical evaluation of cardiac amyloidosis highlighting the utility of various laboratory tests and imaging modalities utilized to facilitate reaching a diagnosis. Herein, we discuss the clinical evaluation of a 69-year-old male with suspected cardiac amyloidosis highlighting the utility of various laboratory tests and imaging modalities to reach a diagnosis. Additionally, we discuss the pitfalls of delayed diagnosis.

Keywords

amyloidosis, echocardiography, red flags

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy..
[2]	Witteles RM, Liedtke M. AL amyloidosis for the cardiologist and oncologist: epidemiology, diagnosis, and management. JACC CardioOncol. (2019) 1: 117-30.
[3]	Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen Howard J, et al. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American heart association. Circulation. (2020) 142: e7-22.
[4]	Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: evidence base and standardized methods of imaging. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. (2019) 26: 2065-123.
[5]	Cuddy SAM, Falk RH. Amyloidosis as a systemic disease in context. Can J Cardiol. (2020) 36: 396-407.
[6]	Ihne S, Morbach C, Obici L, Palladini G, Störk S. Amyloidosis in heart failure. Curr Heart Fail Rep. (2019) 16: 285-303.